Non-nucleoside-based antiretroviral regimens are most durable and cost-effective as first treatments in an urban setting from a developing country

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.